HHLA3 antibody

Principal name

HHLA3 antibody

Alternative names for HHLA3 antibody

HERV-H LTR-associating protein 3, Human endogenous retrovirus-H long terminal repeat-associating protein 3

SwissProt ID

Q9XRX5 (Human)

Gene ID

11147 (HHLA3)

Available reactivities

Hu (Human)

Available hosts

Mouse

Available applications

Enzyme Immunoassay (E), Western blot / Immunoblot (WB)

Background of HHLA3 antibody

Kit Component:
- KN203092G1, HHLA3 gRNA vector 1 in pCas-Guide vector
- KN203092G2, HHLA3 gRNA vector 2 in pCas-Guide vector
- KN203092D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

14 Item(s)

per page

CRISPR

Catalog No. Species Donor Vector  

HHLA3 - human gene knockout kit via CRISPR

HHLA3 - human gene knockout kit via CRISPR Human GFP-Puro
1 kit / €1,200.00
  OriGene Technologies, Inc.

HHLA3 - human gene knockout kit via CRISPR

HHLA3 - human gene knockout kit via CRISPR Human mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

HHLA3 - human gene knockout kit via CRISPR

HHLA3 - human gene knockout kit via CRISPR Human Luciferase-Puro
1 kit / €1,290.00
  OriGene Technologies, Inc.

HHLA3 - human gene knockout kit via CRISPR

HHLA3 - human gene knockout kit via CRISPR Human RFP-BSD
1 kit / €1,290.00
  OriGene Technologies, Inc.

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

HHLA3 (full length, N-term HIS tag, transcript variant 1)

  Recombinant protein of human HERV-H LTR-associating 3 (HHLA3), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug  
HHLA3 Human > 80 %
Preparation: .
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
E. coli
50 µg / €199.00
  OriGene Technologies, Inc.

Lysates

Catalog No.    

HHLA3 overexpression lysate

HHLA3 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

HHLA3 overexpression lysate

HHLA3 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

HHLA3 overexpression lysate

HHLA3 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, HHLA3 (mGFP-tagged)-Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (mGFP-tagged)-Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, HHLA3 (mGFP-tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (mGFP-tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, HHLA3 (mGFP-tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (mGFP-tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, HHLA3 (Myc-DDK-tagged)-Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (Myc-DDK-tagged)-Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, HHLA3 (Myc-DDK tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2 , 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (Myc-DDK tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 2 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, HHLA3 (Myc-DDK tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 3 , 200 uL, >10^7 TU/mL

Lenti ORF particles, HHLA3 (Myc-DDK tagged) - Human HERV-H LTR-associating 3 (HHLA3), transcript variant 3 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

14 Item(s)

per page
  • LinkedIn